DaVita HealthCare Partners Inc (DVA)
DaVita HealthCare Partners Inc. is a common stock listing on the NYSE under the ticker DVA. The company, now known as DaVita Inc., focuses on kidney dialysis and related care for patients with chronic kidney failure in the United States. Its operations include outpatient dialysis centers, hospital inpatient and home-based hemodialysis services, and clinical laboratory testing for dialysis patients and other physician-prescribed ESRD tests. DaVita also provides management and administrative support to outpatient centers, integrated care and disease management services, clinical research programs, physician services, comprehensive kidney care, and transplant software solutions. Incorporated in 1994 and headquartered in Denver, Colorado, the company operates within the healthcare providers and services sector.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Dividend Yield | P/E Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-DVA
|
$186.22
|
1.4% Upside
|
Fair
|
$219.86
|
19.7% Upside
|
Undervalued
|
Great
|
0.0%
|
14.2x
|
0.8x
|
11.711 B
|
26.273 B
|
49.3%
|
53.2%
|
2.7
|
195.7%
|
